5 completed, 2 not yet recruiting, 2 unknown, 1 terminated. 3 Phase 2, 2 Not applicable, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Pityriasis: new trials by email Literature Review of Pityriasis trials Research Report on Pityriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris (PRP) Bimekizumab - Pityriasis Rubra Pilaris | Phase 4 | Not yet recruiting | Mayo Clinic | 12 | 2026-10-01 | 2026-09-08 |
| Interleukin-4 in Pityriasis Lichenoides Chronica skin biopsy and serum sample - Pityriasis Lichenoides | Not applicable | Not yet recruiting | Cairo University | 50 | 2025-04-01 | 2025-03-21 |
| Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris Deucravacitinib - Pityriasis Rubra Pilaris | Phase 2 | Completed | Mayo Clinic | 7 | 2024-07-29 | 2026-08-26 |
| Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19). Cutaneous Manifestations, Skin Manifestations | Completed | Jinnah Postgraduate Medical Centre | 1206 | 2020-07-31 | 2021-11-22 | |
| Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP) guselkumab - Pityriasis Rubra Pilaris | Phase 2 | Completed | Oregon Health and Science University | 15 | 2019-10-03 | 2024-05-24 |
| Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up Pityriasis Lichenoides | Unknown | Assistance Publique - Hôpitaux de Paris | 52 | 2019-05-01 | 2019-04-19 | |
| Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin Azithromycin, nbUVB - Pityriasis Lichenoides | Not applicable | Unknown | Cairo University | 30 | 2019-02-01 | 2019-02-05 |
| Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) Ixekizumab - Pityriasis Rubra Pilaris | Phase 2 | Completed | Oregon Health and Science University | 12 | 2018-05-23 | 2020-07-01 |
| Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris Cosentyx - PITYRIASIS RUBRA PILARIS | Phase 1 | Completed | Mayo Clinic | 12 | 2018-04-01 | 2022-02-24 |
| A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris Alefacept - Pityriasis Rubra Pilaris | Phase 4 | Terminated | Joshua Zeichner | 1 | 2008-12-01 | 2018-05-11 |
Pityriasis Rubra Pilaris (6) · Pityriasis Lichenoides (3) · COVID-19 (1) · Candidiasis, Oral (1) · Chilblains (1) · Coronavirus Infections (1) · Erythema Multiforme (1) · Herpes Zoster (1) · Livedo Reticularis (1) · Lymphoma, T-Cell, Cutaneous (1) · Pityriasis Rosea (1) · Pruritus (1) · Purpura Fulminans (1) · Scabies (1) · Skin Diseases (1)
Skin Diseases, Papulosquamous (10) · Skin and Connective Tissue Diseases (10) · Skin Diseases (9) · Lichenoid Eruptions (3) · Parapsoriasis (3) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Bacterial Infections and Mycoses (1) · Blood Coagulation Disorders (1) · Candidiasis (1) · Cardiovascular Diseases (1) · Cold Injury (1) · Coronaviridae Infections (1) · DNA Virus Infections (1)
Alefacept (1) · Azithromycin (1) · bimekizumab (1) · deucravacitinib (1) · guselkumab (1) · ixekizumab (1) · secukinumab (1)
Mayo Clinic (3) · Cairo University (2) · Oregon Health and Science University (2) · Assistance Publique - Hôpitaux de Paris (1) · Jinnah Postgraduate Medical Centre (1) · Joshua Zeichner (1)
United States (6) · Egypt (1) · Pakistan (1)
Teri Greiling, MD, PhD (2) · Aaron Mangold, MD (1) · Jason C Sluzevich (1) · Jason C. Sluzevich, MD (1) · Joshua Zeichner, MD (1) · Rabia Ghafoor, MBBS, FCPS, SCE-Derm(MRCP-UK) (1) · Syeda Mahanum Ali, MBBS, Postgraduate Trainee (1)